DLS Portal Maintenance Outage September 2025

The DLS Portal will be offline for maintenance and upgrades from 6.00pm (AEST) Friday, 12 September 2025 to 8.00am (AEST) Monday, 15 September 2025.

AstraZeneca AB v Apotex Pty Ltd

[2015] HCA 30
Judgment date
Case number
S54/2015
S55/2015
S56/2015
Before
French CJ, Kiefel, Gageler, Keane, Nettle JJ
Catchwords

Intellectual property – Patents – Patents Act 1990 (Cth) – Inventive step – Obviousness – Patent disclosing method of treatment for hypercholesterolemia – Administration of rosuvastatin and its pharmaceutically acceptable salts at low dosage range in claims – Whether invention obvious in light of common general knowledge together with two prior art documents considered separately where another prior art document disclosed alternative compound – Whether prior art documents were ascertained, understood and regarded by person skilled in relevant art as relevant – Whether permissible to use information from other documents to determine relevance of information in prior art document – Use of prior art not within common general knowledge.

Words and phrases – "ascertained, understood and regarded as relevant", "considered separately", "inventive step", "obviousness", "person skilled in the relevant art".

Patents Act 1990 (Cth) – s 7(2), (3), s 18(1)(b).

Files
30.rtf (470.48 KB)
30.pdf (289.27 KB)